Wednesday, August 5, 2020

Strategies for Tapering and Discontinuing Antidepressants

A new review of strategies to support both patients and practitioners through the process of discontinuing antidepressants.

Randomized Controlled Trial Confirms That Antipsychotics Damage the Brain

A new study published in JAMA Psychiatry connects antipsychotics with damage to the brain in multiple areas.

For People “At Risk for Psychosis,” Antipsychotics Associated with Worse Outcomes

Researchers studied whether antipsychotics could prevent transition to full psychosis and found that the drugs worsened outcomes.

Neuropsychological Tests Reveal Consequences of Polypharmacy

Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.

Mental Health and Emotion in the Digital Age: An Interview with Ian Tucker

MIA's Tim Beck interviews psychologist Ian Tucker about the relationships between digital technologies, emotion, and mental health.

When Psychology Speaks for You, Without You: Sunil Bhatia on Decolonizing Psychology

MIA’s Ayurdhi Dhar interviews Sunil Bhatia about decolonizing psychology, confronting the field’s racist past, colonial foundations, and neoliberal present.

Antidepressants Blunt Ability to Feel Empathy

A new study suggests that taking antidepressants impairs empathy, while the experience of depression itself does not.

Study Finds ADHD Drugs Alter Developing Brain

A new study, published in the JAMA Psychiatry, investigates the effect of stimulant ‘ADHD’ drugs on the brains of children and young adults. The...

Stopping SSRI Antidepressants Can Cause Long, Intense Withdrawal Problems

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

Psychology is Not What You Think: An Interview with Critical Psychologist Ian Parker

MIA’s Ayurdhi Dhar interviews Ian Parker about critical psychology, discourse and political action, and whether psychology has anything left to offer.

Lithium May Cause Sexual Dysfunction — More Research Needed

Lithium appears to reduce libido and sexual function, and more research into the problem is needed.

Researchers: Antidepressant Withdrawal, Not “Discontinuation Syndrome”

Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.

School Discipline is Racially Biased and Increases Misbehavior

School discipline that punishes minor misbehavior may increase adolescents’ misconduct and lead to racial inequalities in school discipline.

Antipsychotic Trials Show Increasing Placebo Response and Declining Drug Response

A new review of antipsychotic trials conducted over the last 24 years finds that the placebo response rate is steadily increasing, and drug response is decreasing.

Researchers: “Antidepressants Should Not be Used for Adults with Major Depressive Disorder”

A new review, published in BMJ Evidence-Based Medicine, concludes that antidepressants should not be used as the risks outweigh evidence for benefits.

Anticholinergic Psychiatric Drugs Linked to a 50% Increase in Dementia

People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.

Review Explores First-Person Experiences of People Taking Antipsychotics

A new systematic review finds that patients report reduced symptoms but also loss of self and agency while taking antipsychotics.

Is Long-term Use of Benzodiazepines a Risk for Cancer?

A large study of the population in Taiwan reveals that long-term use of benzodiazepine drugs, commonly prescribed for anxiety, significantly increases the risk for brain, colorectal, and lung cancers. The research, published open-access in the journal Medicine, also identifies the types of benzodiazepines that carry the greatest cancer risk.

Use of Antidepressants Linked to Diabetes

Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...

Belgian Guidelines Recommend “DSM Categories Not be at the Centre of Care Planning”

The Superior Health Council of Belgium documents numerous problems with the evidence base in the manuals used to diagnose “mental illness” and cautions against their use.

Involuntary Hospitalization Increases Risk of Suicide, Study Finds

New study finds that people who felt they were coerced into being hospitalized were more likely to attempt suicide later.

Psychiatrist Describes Role in Open Dialogue Model of Care

Psychiatrist outlines varying roles in Open Dialogue model, fostering service-user and family agency through meaningful conversations with a team of providers.

NICE Guideline Update Acknowledges Severe Antidepressant Withdrawal

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

Initial Trial of Ayahuasca for Depression Shows Promising Results

Ayahuasca found to be effective in treating moderate to severe depression in low-income population.

Researchers Find Paroxetine Harms Developing Brain

Researchers at Johns Hopkins test paroxetine on developing brain cells and discover numerous neurotoxic effects.

Follow Us

19,639FansLike
11,994FollowersFollow
3,820SubscribersSubscribe